Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean C Murphy

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Malaria Journal|April 2, 2020
WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to threeJane A Cunningham, Rebecca M Thomson, Sean C Murphy, et al.
Malaria Journal|July 29, 2018
Plasmodium 18S rRNA of intravenously administered sporozoites does not persist in peripheral bloodSean C Murphy, Andrew S Ishizuka, Zachary P Billman, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
<i>Plasmodium vivax</i> latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquineErika L Flannery, Niwat Kangwanrangsan, Vorada Chuenchob, et al.
Frontiers in Immunology|March 18, 2026
Host biological sex directs immune control of the <i>Plasmodium</i> parasite liver stage in miceCaroline J Duncombe, Alen S Poehlman, Ethan N Conrad, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Iscience|January 1, 2024
More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malariaNaveen Yadav, Chaitra Parthiban, Zachary P Billman, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Malaria Journal|March 24, 2025
WHO malaria nucleic acid amplification test external quality assessment scheme: results of eleven distributions over 6 yearsRebecca M Thomson, Jane A Cunningham, Michelle M Gatton, et al.
Plos One|November 19, 2014
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challengeAngela K Talley, Sara A Healy, Olivia C Finney, et al.
The Lancet. Microbe|January 16, 2026
Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysisCaroline J Duncombe, Dianna E B Hergott, Weston Staubus, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Malaria Journal|April 2, 2020
WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to threeJane A Cunningham, Rebecca M Thomson, Sean C Murphy, et al.
Malaria Journal|July 29, 2018
Plasmodium 18S rRNA of intravenously administered sporozoites does not persist in peripheral bloodSean C Murphy, Andrew S Ishizuka, Zachary P Billman, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
<i>Plasmodium vivax</i> latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquineErika L Flannery, Niwat Kangwanrangsan, Vorada Chuenchob, et al.
Frontiers in Immunology|March 18, 2026
Host biological sex directs immune control of the <i>Plasmodium</i> parasite liver stage in miceCaroline J Duncombe, Alen S Poehlman, Ethan N Conrad, et al.
Diagnostic Microbiology and Infectious Disease|November 6, 2023
Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine developmentMing Chang, Sambasivan Venkatasubramanian, Holly Barrett, et al.
Iscience|January 1, 2024
More time to kill: A longer liver stage increases T cell-mediated protection against pre-erythrocytic malariaNaveen Yadav, Chaitra Parthiban, Zachary P Billman, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Malaria Journal|March 24, 2025
WHO malaria nucleic acid amplification test external quality assessment scheme: results of eleven distributions over 6 yearsRebecca M Thomson, Jane A Cunningham, Michelle M Gatton, et al.
Plos One|November 19, 2014
Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challengeAngela K Talley, Sara A Healy, Olivia C Finney, et al.
The Lancet. Microbe|January 16, 2026
Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysisCaroline J Duncombe, Dianna E B Hergott, Weston Staubus, et al.
Pageof 13